This year's report is 134 pages...42 pages longer than the 2010-11 report. It includes expanded coverage of specialty pharmaceuticals, new market data, and more-detailed analyses of reimbursement trends. The 2011-12 report also updates 5 key trends that will affect the market structure and economics of the retail and specialty pharmacy industries.
All information is updated through 2011, including 62 data-packed exhibits. True hardcore Drug Channels readers can savor 183 endnotes (!), most of which have hyperlinks to original source materials.
I'm sure you'll enjoy the latest edition. As a special bonus, see below for a picture of me with the heretofore unacknowledged inspiration behind this new report.
The 2011–12 Economic Report on Retail and Specialty Pharmacies is a comprehensive resource with the latest facts and data about all aspects of the U.S. pharmacy distribution and reimbursement system—product movement, financial flows, and contractual relationships.
I worked hard to make it an essential resource for pharmaceutical manufacturers, wholesalers, pharmacy owners, benefit managers, managed care executives, healthcare policy analysts, investors—anyone who wants to understand and benefit from this ever-evolving industry.
Here's more info to help you review the breadth and depth of content:
- View the Table of Contents
- View the List of Exhibits
- Download a free Overview of the Report.
AND SPECIAL THANKS TO...
I want to give a special shout out to Count von Count, the world's most famous arithmomaniac. He was a great inspiration. One prescription, two prescriptions, three prescriptions...ha, ha, ha!!